# Efficacy and Safety of Nexpowder™ for Non-variceal, Upper Gastrointestinal Bleeding

> **NCT06269588** · NA · UNKNOWN · sponsor: **Changi General Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Gastrointestinal Hemorrhage
- Hematemesis; With Ulcer
- Endoscopy

## Interventions

- **DEVICE:** Nexpowder

## Key facts

- **NCT ID:** NCT06269588
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06269588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06269588, "Efficacy and Safety of Nexpowder™ for Non-variceal, Upper Gastrointestinal Bleeding". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06269588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*